Business
CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia
VIENNA, Va., May 11, 2026--CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia.
About this update from Cel-sci Corporation
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":240,"url":"https://media.zenfs.com/en/business-wire.com/d435531d952081355671aed9186ae3c7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/12ihIGSHxelbvBW7bI_rcA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MA--/https://media.zenfs.com/en/business-wire.com/d435531d952081355671aed9186ae3c7","width":480,"height":240},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/Q_x0zCO18EAo0Zg5IpyFhw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTMyMA--/https://media.zenfs.com/en/business-wire.com/d435531d952081355671aed9186ae3c7","width":480,"height":240}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"50%/50% revenue sharing agreement for Multikine sales in Saudi Arabia upon receipt of Breakthrough Medicine Designation ","length":119,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Amarox to act as the local regulatory representative and lead all communications with the Saudi Food and Drug Authority (SFDA)","length":126,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Amarox ranked #1 for SFDA applications for critical and unavailable medicine for 3 consecutive years","length":100,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Amarox to be exclusive commercial distributor of Multikine in Saudi Arabia, upon SFDA approval, with optional expansion to GCC countries ","length":136,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Immunotherapy is among the fastest-growing segments in the Saudi cancer market, projected to reach $2.7 billion by 2033","length":119,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":600,"olType":false},{"type":"text","content":"VIENNA, Va., May 11, 2026--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) today announced it has signed a strategic partnership, distribution, and revenue sharing agreement with Amarox for regulatory affairs, marketing and potential commercialization of *Multikine® (Leukocyte Interleukin, Injection) in the treatment of head and neck cancer in Saudi Arabia, with an optional extension for the Gulf Cooperation Council (GCC) countries including Bahrain, Kuwait, Oman, Qatar, and the United Arab Emirates.","length":515,"tagName":"p"},{"type":"t...